Tissue expanders, effect

As new compounds, very limited research has been done to evaluate the biological effects of ionic liquids. The topical effect of [EMIM]C1/A1C13 melts and [EMIMjCl on the integument of laboratory rat has been investigated. The study reports that [EMIMjCl is not in itself responsible for tissue damage. However, the chloroaluminate salt can induce tissue irritation, inflammation, and necrosis, due to the presence of aluminium chloride. However, treatments for aluminium chloride and hydrochloric acid are well documented. This study needs to be expanded to the other ionic liquids, and their toxicity need to be investigated [46]. 

Sato et al. (1991) expanded their earlier PBPK model to account for differences in body weight, body fat content, and sex and applied it to predicting the effect of these factors on trichloroethylene metabolism and excretion. Their model consisted of seven compartments (lung, vessel rich tissue, vessel poor tissue, muscle, fat tissue, gastrointestinal system, and hepatic system) and made various assumptions about the metabolic pathways considered. First-order Michaelis-Menten kinetics were assumed for simplicity, and the first metabolic product was assumed to be chloral hydrate, which was then converted to TCA and trichloroethanol. Further assumptions were that metabolism was limited to the hepatic compartment and that tissue and organ volumes were related to body weight. The metabolic parameters, (the scaling constant for the maximum rate of metabolism) and (the Michaelis constant), were those determined for trichloroethylene in a study by Koizumi (1989) and are presented in Table 2-3. 

A further characteristic of this principle is that, if the activity of phosphodiesterase is decreased, the concentration of cyclic GMP will increase to an extent dependent upon the extent of the decrease in activity. This characteristic has been made use of by the pharmaceutical industry. Cyclic GMP has a vasodilatory effect and this is the case for the arterioles that supply blood to the corpus cavemosum in the penis, which controls the erection of the penis. Drugs were developed (e.g. sildenafil) that inhibits cyclic GMP phosphodiesterase and hence increases the cyclic GMP level which resnlts in vasodilation of the arterioles and an increase in the snpply of blood to the spongy tissue of the corpus cavemosum, which expands resulting in erection. This dmg has been found to be effective in some patients snffering from erectile dysfunction. This can be a particular problem in diabetic patients and more elderly men (Chapter 19). 

Linezolid s a novel oxazolidinone antibiotic with exclusively Gram-positive activity (including MRSA) which acts at the level of the 30S and 70S ribosomal subunits by a unique mechanism it inhibits protein synthesis by preventing formation of initiation complexes. Linezolid has excellent oral bioavailability and tissue penetration the most important adverse effect is marrow suppression which is usually reversible. Its major indications are soft tissue infections and nosocomial pneumonia, although these will probably expand in the future. 

Efforts continue to develop other SERMs that will capitalize on the beneficial effects of estrogen while minimizing or even reducing the carcinogenic effects of estrogen on other tissues. As newer agents are developed, SERMs may have an expanded role in the treatment of various diseases and perhaps provide a safer and more effective method of estrogen replacement.54,59... 

---